"Teva has what it takes to fully characterize Lovenox to the FDA’s satisfaction. When the FDA needed help last year to figure out the contamination problem with Chinese heparin, the FDA turned to MNTA, not Teva"
If TEVA's drug is not a fully characterized Lovenox, could MNTA's technology be used to prove it?